menu
    • menu

    Company profile for Metsera

    NEW Drugs in Dev: 4
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Metsera is a clinical-stage biopharmaceutical company focused on spearheading the development of cutting-edge medicines and solutions for obesity and metabolic diseases. Founded in collaboration between Population Health Partners and ARCH Venture Partners, Metsera is fast-tracking the advancement of new medicines with potential best-in-class profiles. we are accelerating the discovery and development of innovative therapies ai...
    Metsera is a clinical-stage biopharmaceutical company focused on spearheading the development of cutting-edge medicines and solutions for obesity and metabolic diseases. Founded in collaboration between Population Health Partners and ARCH Venture Partners, Metsera is fast-tracking the advancement of new medicines with potential best-in-class profiles. we are accelerating the discovery and development of innovative therapies aimed at addressing the significant unmet needs in the field of obesity and metabolic diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MetseraUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3 World Trade Ctr 175 Greenwich St New York, NY 10007 United States
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://metsera.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASCO GU

    ASCO GU

    Not Confirmed

    envelop Contact Supplier

    ASCO GU

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amylin's Oral Obesity Assets Gain Momentum In 2026
    Amylin's Oral Obesity Assets Gain Momentum In 2026

    06 Feb 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/obesity-space-abuzz-with-oral-amylin-assets-as-momentum-rides-into-2026

    BIOSPACE
    06 Feb 2026
    Share Share
    Pfizer Links Monthly GLP-1 To Competitive Weight Loss In Phase 2
    Pfizer Links Monthly GLP-1 To Competitive Weight Loss In Phase 2

    04 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/pfizers-10b-monthly-glp-1-bet-generates-competitive-weight-loss-phase-2b

    FIERCE BIOTECH
    04 Feb 2026
    Share Share
    Pfizer Metsera Data, 2025 Earnings; FDA Eyes REGENXBIO
    Pfizer Metsera Data, 2025 Earnings; FDA Eyes REGENXBIO

    04 Feb 2026

    // BIOSPACE

    https://www.biospace.com/business/pfizers-metsera-data-2025-earnings-the-fda-and-regenxbio-psychedelics-and-ipos

    BIOSPACE
    04 Feb 2026
    Share Share
    With 200 JPM Meetings, Novo BD Head Seeks Out The Next Metsera
    With 200 JPM Meetings, Novo BD Head Seeks Out The Next Metsera

    27 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/200-jpm-pitches-novo-nordisk-bd-head-searches-next-metsera

    FIERCE BIOTECH
    27 Jan 2026
    Share Share
    Novo Pursues Strategic Move To Advance Metsera Treatment
    Novo Pursues Strategic Move To Advance Metsera Treatment

    16 Jan 2026

    // BIOSPACE

    https://www.biospace.com/business/deal-hungry-novo-moves-with-intention-to-put-metsera-in-the-rearview

    BIOSPACE
    16 Jan 2026
    Share Share
    Pfizer Expedites Obesity Programs Amid Patent Cliff Challenge
    Pfizer Expedites Obesity Programs Amid Patent Cliff Challenge

    13 Jan 2026

    // BIOSPACE

    https://www.biospace.com/business/jpm26-pfizer-fast-tracks-obesity-programs-in-race-against-patent-cliff

    BIOSPACE
    13 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search